Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial
Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.SummaryDifference3%

- Check36 days agoChange DetectedUpdated the page from v3.0.2 to v3.1.0, signaling a new software release version.SummaryDifference0.1%

- Check50 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2. The 'Back to Top' element was removed, representing a minor UI update with no substantive changes to core content, pricing, stock, or time slot information.SummaryDifference0.2%

- Check57 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

- Check65 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific location details and drug information have been removed.SummaryDifference2%

- Check79 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.